Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma
Clinical trial NCT07324629 · RECRUITING
Trial details
- NCT number
- NCT07324629
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-13
- Primary completion
- 2028-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.